Study Reveals How Brain Imaging Could Personalise Parkinson’s Treatment

Study Reveals How Brain Imaging Could Personalise Parkinson’s Treatment

Publication date: Jul 05, 2025

In other words, we could see the drug activating brain regions we dont want to be activating, and thats getting in the way of the helpful effects. Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinsons drug levodopa doesnt work equally well for everyone. (With ANI Inputs)ALSO READ: 22 Heart Attack Deaths In 40 Days: Karnatakas Hassan District

Concepts Keywords
Drugs Brain
Helpful Drug
Magnetoencephalography Effects
Parkinsons Imaging
Sweden Levodopa
Meg
Movement
Neurodegenerative
Parkinsons
Regions
Signals
Symptoms
Target
Treatment
Wiesman

Semantics

Type Source Name
drug DRUGBANK Levodopa
disease MESH Movement Disorders
drug DRUGBANK Dopamine
disease MESH neurodegenerative disorder
disease MESH brain disorders
disease MESH epilepsy
disease MESH autism
disease MESH mental illness
disease MESH tremors
drug DRUGBANK Isoxaflutole
drug DRUGBANK Tropicamide
disease MESH Heart Attack

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *